April 18, 2023: U.S. Patent No. 11,628,226 "Methods and Gene Therapy Constructs for Treating GM2 Gangliosidoses"

Queen’s Partnerships and Innovation is pleased to report the issuance of U.S. Patent No. 11,628,226 entitled, "Methods and Gene Therapy Constructs for Treating GM2 Gangliosidoses," on April 18, 2023 to Jagdeep Singh Walia. The patent relates to novel gene therapy constructs containing both HEXA and HEXB genes to treat GM2 gangliosidoses, including Sandhoff disease and Tay-Sach's disease.

U.S. Patent No. 11,628,226 (PDF, 4.6 MB)